Optimizing viral spiking levels and process parameters for realistic worst case Optimizing Viral Spiking Levels and Process Parameters for Realistic Worst Case Conditions As regulatory professionals in the pharmaceutical and biotechnology sectors, it is essential to understand the significance of viral clearance and biological safety validation. This comprehensive guide will delve into the regulatory affairs context of designing viral spiking studies and modeling worst-case scenarios. It will equip you with the knowledge to optimize your viral spiking study design while adhering to relevant guidelines and regulations across the US, UK, and EU. Context Viral contamination poses a significant risk to…

Designing viral spiking studies for continuous and intensified bioprocessing Designing viral spiking studies for continuous and intensified bioprocessing Context The successful implementation of viral clearance studies is essential in ensuring the safety of biopharmaceutical products. Viral spiking studies are particularly important in demonstrating that bioprocessing steps can effectively remove or inactivate potential contaminants. Regulatory agencies such as the FDA, EMA, and MHRA require comprehensive validation to confirm these processes, especially given the complexities introduced by continuous and intensified bioprocessing systems. This article aims to provide a detailed regulatory framework for the design of viral spiking studies, focusing on the methodologies,…

Bridging viral spiking study data when process parameters or scale change Bridging Viral Spiking Study Data When Process Parameters or Scale Change In the realm of biopharmaceutical development, establishing the viral safety of products through viral clearance studies is critical. Among the numerous methodologies employed, viral spiking study design is a prominent technique used to assess the ability of a manufacturing process to remove or inactivate viruses. However, changes in process parameters or scale can pose challenges in ensuring that the data remains applicable. This article serves as a comprehensive guide for regulatory affairs (RA) professionals in the US, UK,…

Using Design of Experiments to Streamline Viral Spiking Study Design Using Design of Experiments to Streamline Viral Spiking Study Design In the realm of biopharmaceutical development, ensuring the safety and efficacy of products is paramount. Integral to this process is the validation of viral clearance, particularly through well-designed viral spiking studies. This regulatory explainer manual outlines the key aspects of viral spiking study design, the incorporation of worst-case models, and the utilization of design of experiments (DOE) principles to optimize the process. Regulatory Affairs Context Viral clearance studies are critical for assessing the capacity of manufacturing processes to remove or…

Vendor qualification framework for virus filter and resin suppliers Vendor Qualification Framework for Virus Filter and Resin Suppliers Context In the realm of biopharmaceutical manufacturing, virus filters and chromatography resins play essential roles in ensuring the safety and efficacy of biological products. Regulatory Affairs (RA) professionals must robustly evaluate vendors of these critical components to ensure that they comply with stringent quality standards. This article outlines the vendor qualification process for virus filter and resin suppliers in the context of US, UK, and EU regulations, focusing on best practices to establish an effective framework for vendor qualification. Legal/Regulatory Basis The…

Quality agreements for virus filter vendors in GMP biologics manufacturing Quality agreements for virus filter vendors in GMP biologics manufacturing The qualification of virus filter vendors plays a crucial role in ensuring the biological safety of products in Good Manufacturing Practice (GMP) biologics manufacturing. This regulatory explainer manual delves into the context, legal bases, documentation requirements, and review flows necessary for effective vendor qualification in this specialized area. Context Viral contamination of biological products represents a significant concern for manufacturers and regulators alike. Virus filters serve as a primary barrier against viral contamination during the production of biopharmaceuticals. Consequently, rigorous…

Supplier audit checklist for virus filter and resin manufacturers Supplier audit checklist for virus filter and resin manufacturers Context In the evolving landscape of biopharmaceutical production, ensuring the safety and efficacy of biological products is paramount. A key aspect of this is the validation of viral safety through effective methods such as virus filters and resin purification systems. The virus filter vendor qualification process is crucial as it establishes the reliability of suppliers in manufacturing safe and compliant filtration systems. This article serves as a comprehensive guide focused on the regulatory requirements, guidance, and practical considerations for conducting supplier audits…

Managing extractables and leachables from single use systems and virus filters Managing Extractables and Leachables from Single-Use Systems and Virus Filters Context In the evolving landscape of biological product development, ensuring the safety and efficacy of pharmaceuticals and biologics is paramount. A significant portion of this responsibility falls on regulatory affairs (RA) professionals who must navigate complex guidelines concerning the qualification of virus filter vendors, particularly regarding extractables and leachables (E&L) from single-use systems and virus filters. This article serves as a regulatory explainer manual that outlines key regulations, guidelines, and agency expectations related to the qualification of vendors and…

Vendor change notifications and impact on viral clearance validation Vendor change notifications and impact on viral clearance validation Context In the highly regulated fields of pharmaceuticals and biotechnology, ensuring the safety and efficacy of biological products is paramount. A crucial aspect of this assurance lies in the effectiveness of viral clearance processes. One particularly sensitive area within this domain is the virus filter vendor qualification. As organizations adopt single-use systems and engage with multiple resin suppliers, they face the challenge of maintaining compliance while managing changes in their supply chain, specifically vendor changes. This article will explore the regulatory expectations,…

Global sourcing strategies for virus filters and resins with regulatory confidence Global sourcing strategies for virus filters and resins with regulatory confidence Regulatory Affairs Context In the biotech and pharmaceutical industries, ensuring the safety and efficacy of therapeutic products is paramount. One critical aspect of this process involves the implementation of virus filters and resins that effectively eliminate potential viral contaminants during the production of biologicals. Vendor qualification for virus filters and the associated resins used in single-use systems is not only a best practice but also a regulatory requirement. The regulatory landscape surrounding these practices is complex, reflecting the…